Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectives.

European heart journal. Cardiovascular pharmacotherapy

Paolillo S, Perrone Filardi P.
PMID: 27533983
Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):132-3. doi: 10.1093/ehjcvp/pvv008. Epub 2015 Feb 24.

No abstract available.

Cite
Paolillo S, Perrone Filardi P. Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectives. Eur Heart J Cardiovasc Pharmacother. 2015;1(2):132-3doi: 10.1093/ehjcvp/pvv008.
Paolillo, S., & Perrone Filardi, P. (2015). Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectives. European heart journal. Cardiovascular pharmacotherapy, 1(2), 132-3. https://doi.org/10.1093/ehjcvp/pvv008
Paolillo, Stefania, and Perrone Filardi, Pasquale. "Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectives." European heart journal. Cardiovascular pharmacotherapy vol. 1,2 (2015): 132-3. doi: https://doi.org/10.1093/ehjcvp/pvv008
Paolillo S, Perrone Filardi P. Cardio-renal protection through renin-angiotensin-aldosterone system inhibition: current knowledge and new perspectives. Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):132-3. doi: 10.1093/ehjcvp/pvv008. Epub 2015 Feb 24. PMID: 27533983.
Copy Download .nbib Format: NLM
The Impact of Social and Cultural Engagement and Dieting on Well-Being and Resilience in a Group of Residents in the Metropolitan Area of Naples.

Journal of aging research

Rapacciuolo A, Perrone Filardi P, Cuomo R, Mauriello V, Quarto M, Kisslinger A, Savarese G, Illario M, Tramontano D.
PMID: 27298737
J Aging Res. 2016;2016:4768420. doi: 10.1155/2016/4768420. Epub 2016 May 19.

Social isolation and exclusion are associated with poor health status and premature death. A number of related isolation factors, inadequate transportation system and restrictions in individuals' life space, have been associated with malnutrition in older adults. Since eating is...

Cite
Rapacciuolo A, Perrone Filardi P, Cuomo R, et al. The Impact of Social and Cultural Engagement and Dieting on Well-Being and Resilience in a Group of Residents in the Metropolitan Area of Naples. J Aging Res. 2016;2016:4768420doi: 10.1155/2016/4768420.
Rapacciuolo, A., Perrone Filardi, P., Cuomo, R., Mauriello, V., Quarto, M., Kisslinger, A., Savarese, G., Illario, M., & Tramontano, D. (2016). The Impact of Social and Cultural Engagement and Dieting on Well-Being and Resilience in a Group of Residents in the Metropolitan Area of Naples. Journal of aging research, 20164768420. https://doi.org/10.1155/2016/4768420
Rapacciuolo, Antonio, et al. "The Impact of Social and Cultural Engagement and Dieting on Well-Being and Resilience in a Group of Residents in the Metropolitan Area of Naples." Journal of aging research vol. 2016 (2016): 4768420. doi: https://doi.org/10.1155/2016/4768420
Rapacciuolo A, Perrone Filardi P, Cuomo R, Mauriello V, Quarto M, Kisslinger A, Savarese G, Illario M, Tramontano D. The Impact of Social and Cultural Engagement and Dieting on Well-Being and Resilience in a Group of Residents in the Metropolitan Area of Naples. J Aging Res. 2016;2016:4768420. doi: 10.1155/2016/4768420. Epub 2016 May 19. PMID: 27298737; PMCID: PMC4889833.
Copy Download .nbib Format: NLM
Erratum to: Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study.

Journal of thrombosis and thrombolysis

Schaffer A, Verdoia M, Cassetti E, Barbieri L, Perrone-Filardi P, Marino P, De Luca G.
PMID: 25800883
J Thromb Thrombolysis. 2015 Jul;40(1):69. doi: 10.1007/s11239-015-1206-6.

No abstract available.

Cite
Schaffer A, Verdoia M, Cassetti E, et al. Erratum to: Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study. J Thromb Thrombolysis. 2015;40(1):69doi: 10.1007/s11239-015-1206-6.
Schaffer, A., Verdoia, M., Cassetti, E., Barbieri, L., Perrone-Filardi, P., Marino, P., & De Luca, G. (2015). Erratum to: Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study. Journal of thrombosis and thrombolysis, 40(1), 69. https://doi.org/10.1007/s11239-015-1206-6
Schaffer, Alon, et al. "Erratum to: Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study." Journal of thrombosis and thrombolysis vol. 40,1 (2015): 69. doi: https://doi.org/10.1007/s11239-015-1206-6
Schaffer A, Verdoia M, Cassetti E, Barbieri L, Perrone-Filardi P, Marino P, De Luca G. Erratum to: Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study. J Thromb Thrombolysis. 2015 Jul;40(1):69. doi: 10.1007/s11239-015-1206-6. PMID: 25800883.
Copy Download .nbib Format: NLM
Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure.

Heart (British Cardiac Society)

Scala O, Paolillo S, Formisano R, Pellegrino T, Rengo G, Gargiulo P, De Michele F, Starace A, Rapacciuolo A, Parisi V, Prastaro M, Piscopo V, Dellegrottaglie S, Bruzzese D, De Martino F, Parente A, Leosco D, Trimarco B, Cuocolo A, Perrone-Filardi P.
PMID: 27340199
Heart. 2016 Nov 15;102(22):1813-1819. doi: 10.1136/heartjnl-2015-309215. Epub 2016 Jun 23.

OBJECTIVE: Unfavourable effects of sleep-disordered breathing (SDB) in heart failure (HF) are mainly mediated by impaired sympathetic activity. Few data are available on SDB and cardiac adrenergic impairment evaluated at myocardial level. The aim of the study was to...

Cite
Scala O, Paolillo S, Formisano R, et al. Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure. Heart. 2016;102(22):1813-1819doi: 10.1136/heartjnl-2015-309215.
Scala, O., Paolillo, S., Formisano, R., Pellegrino, T., Rengo, G., Gargiulo, P., De Michele, F., Starace, A., Rapacciuolo, A., Parisi, V., Prastaro, M., Piscopo, V., Dellegrottaglie, S., Bruzzese, D., De Martino, F., Parente, A., Leosco, D., Trimarco, B., Cuocolo, A., & Perrone-Filardi, P. (2016). Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure. Heart (British Cardiac Society), 102(22), 1813-1819. https://doi.org/10.1136/heartjnl-2015-309215
Scala, Oriana, et al. "Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure." Heart (British Cardiac Society) vol. 102,22 (2016): 1813-1819. doi: https://doi.org/10.1136/heartjnl-2015-309215
Scala O, Paolillo S, Formisano R, Pellegrino T, Rengo G, Gargiulo P, De Michele F, Starace A, Rapacciuolo A, Parisi V, Prastaro M, Piscopo V, Dellegrottaglie S, Bruzzese D, De Martino F, Parente A, Leosco D, Trimarco B, Cuocolo A, Perrone-Filardi P. Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure. Heart. 2016 Nov 15;102(22):1813-1819. doi: 10.1136/heartjnl-2015-309215. Epub 2016 Jun 23. PMID: 27340199.
Copy Download .nbib Format: NLM
Use of carotid intima-media thickness regression to guide therapy and management of cardiac risks.

Current treatment options in cardiovascular medicine

Costanzo P, Cleland JG, Atkin SL, Vassallo E, Perrone-Filardi P.
PMID: 22139639
Curr Treat Options Cardiovasc Med. 2012 Feb;14(1):50-6. doi: 10.1007/s11936-011-0158-1.

OPINION STATEMENT: Although carotid intima-media thickness (IMT) has been broadly used as a tool to evaluate cardiovascular risk, its role as a surrogate endpoint is still debated. The main issue is the fact that no study has ever been...

Cite
Costanzo P, Cleland JG, Atkin SL, et al. Use of carotid intima-media thickness regression to guide therapy and management of cardiac risks. Curr Treat Options Cardiovasc Med. 2012;14(1):50-6doi: 10.1007/s11936-011-0158-1.
Costanzo, P., Cleland, J. G., Atkin, S. L., Vassallo, E., & Perrone-Filardi, P. (2012). Use of carotid intima-media thickness regression to guide therapy and management of cardiac risks. Current treatment options in cardiovascular medicine, 14(1), 50-6. https://doi.org/10.1007/s11936-011-0158-1
Costanzo, P, et al. "Use of carotid intima-media thickness regression to guide therapy and management of cardiac risks." Current treatment options in cardiovascular medicine vol. 14,1 (2012): 50-6. doi: https://doi.org/10.1007/s11936-011-0158-1
Costanzo P, Cleland JG, Atkin SL, Vassallo E, Perrone-Filardi P. Use of carotid intima-media thickness regression to guide therapy and management of cardiac risks. Curr Treat Options Cardiovasc Med. 2012 Feb;14(1):50-6. doi: 10.1007/s11936-011-0158-1. PMID: 22139639.
Copy Download .nbib Format: NLM
The "Early Treatment" Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Russo G, Monami M, Perseghin G, Avogaro A, Perrone Filardi P, Senni M, Borghi C, Maggioni AP.
PMID: 33768493
Diabetes Ther. 2021 May;12(5):1445-1461. doi: 10.1007/s13300-021-01045-7. Epub 2021 Mar 25.

INTRODUCTION: There is no consensus on the optimal therapeutic approach to adopt in patients with newly diagnosed type 2 diabetes mellitus (T2DM) to prevent cardiovascular disease (CVD). The study aimed to gather an expert consensus on the hypoglycemic treatment...

Cite
Russo G, Monami M, Perseghin G, et al. The "Early Treatment" Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique. Diabetes Ther. 2021;12(5):1445-1461doi: 10.1007/s13300-021-01045-7.
Russo, G., Monami, M., Perseghin, G., Avogaro, A., Perrone Filardi, P., Senni, M., Borghi, C., & Maggioni, A. P. (2021). The "Early Treatment" Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique. Diabetes therapy : research, treatment and education of diabetes and related disorders, 12(5), 1445-1461. https://doi.org/10.1007/s13300-021-01045-7
Russo, Giuseppina, et al. "The "Early Treatment" Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 12,5 (2021): 1445-1461. doi: https://doi.org/10.1007/s13300-021-01045-7
Russo G, Monami M, Perseghin G, Avogaro A, Perrone Filardi P, Senni M, Borghi C, Maggioni AP. The "Early Treatment" Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique. Diabetes Ther. 2021 May;12(5):1445-1461. doi: 10.1007/s13300-021-01045-7. Epub 2021 Mar 25. PMID: 33768493; PMCID: PMC8099991.
Copy Download .nbib Format: NLM
Echocardiographic Epicardial Adipose Tissue Thickness for Risk Stratification of Patients With Heart Failure.

Frontiers in physiology

Parisi V, Conte M, Petraglia L, Grieco FV, Bruzzese D, Caruso A, Grimaldi MG, Campana P, Gargiulo P, Paolillo S, Attena E, Russo V, Galasso G, Rapacciuolo A, Perrone Filardi P, Leosco D.
PMID: 32116756
Front Physiol. 2020 Feb 05;11:43. doi: 10.3389/fphys.2020.00043. eCollection 2020.

BACKGROUND AND AIMS: Epicardial adipose tissue (EAT) has been shown to be involved in the pathogenesis and progression of heart failure (HF). In this study we aimed to explore the predictive value of echocardiographic EAT thickness on prognosis of...

Cite
Parisi V, Conte M, Petraglia L, et al. Echocardiographic Epicardial Adipose Tissue Thickness for Risk Stratification of Patients With Heart Failure. Front Physiol. 2020;11:43doi: 10.3389/fphys.2020.00043.
Parisi, V., Conte, M., Petraglia, L., Grieco, F. V., Bruzzese, D., Caruso, A., Grimaldi, M. G., Campana, P., Gargiulo, P., Paolillo, S., Attena, E., Russo, V., Galasso, G., Rapacciuolo, A., Perrone Filardi, P., & Leosco, D. (2020). Echocardiographic Epicardial Adipose Tissue Thickness for Risk Stratification of Patients With Heart Failure. Frontiers in physiology, 1143. https://doi.org/10.3389/fphys.2020.00043
Parisi, Valentina, et al. "Echocardiographic Epicardial Adipose Tissue Thickness for Risk Stratification of Patients With Heart Failure." Frontiers in physiology vol. 11 (2020): 43. doi: https://doi.org/10.3389/fphys.2020.00043
Parisi V, Conte M, Petraglia L, Grieco FV, Bruzzese D, Caruso A, Grimaldi MG, Campana P, Gargiulo P, Paolillo S, Attena E, Russo V, Galasso G, Rapacciuolo A, Perrone Filardi P, Leosco D. Echocardiographic Epicardial Adipose Tissue Thickness for Risk Stratification of Patients With Heart Failure. Front Physiol. 2020 Feb 05;11:43. doi: 10.3389/fphys.2020.00043. eCollection 2020. PMID: 32116756; PMCID: PMC7013047.
Copy Download .nbib Format: NLM
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry.

European journal of preventive cardiology

Cittadini A, Salzano A, Iacoviello M, Triggiani V, Rengo G, Cacciatore F, Maiello C, Limongelli G, Masarone D, Perticone F, Cimellaro A, Perrone Filardi P, Paolillo S, Mancini A, Volterrani M, Vriz O, Castello R, Passantino A, Campo M, Modesti PA, De Giorgi A, Monte IP, Puzzo A, Ballotta A, D'Assante R, Arcopinto M, Gargiulo P, Sciacqua A, Bruzzese D, Colao A, Napoli R, Suzuki T, Eagle KA, Ventura HO, Marra AM, Bossone E.
PMID: 33693736
Eur J Prev Cardiol. 2021 Dec 29;28(15):1691-1700. doi: 10.1093/eurjpc/zwab020.

AIMS: Recent evidence supports the occurrence of multiple hormonal and metabolic deficiency syndrome (MHDS) in chronic heart failure (CHF). However, no large observational study has unequivocally demonstrated its impact on CHF progression and outcome. The T.O.S.CA. (Trattamento Ormonale nello...

Cite
Cittadini A, Salzano A, Iacoviello M, et al. Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry. Eur J Prev Cardiol. 2021;28(15):1691-1700doi: 10.1093/eurjpc/zwab020.
Cittadini, A., Salzano, A., Iacoviello, M., Triggiani, V., Rengo, G., Cacciatore, F., Maiello, C., Limongelli, G., Masarone, D., Perticone, F., Cimellaro, A., Perrone Filardi, P., Paolillo, S., Mancini, A., Volterrani, M., Vriz, O., Castello, R., Passantino, A., Campo, M., Modesti, P. A., De Giorgi, A., Monte, I. P., Puzzo, A., Ballotta, A., D'Assante, R., Arcopinto, M., Gargiulo, P., Sciacqua, A., Bruzzese, D., Colao, A., Napoli, R., Suzuki, T., Eagle, K. A., Ventura, H. O., Marra, A. M., Bossone, E. (2021). Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry. European journal of preventive cardiology, 28(15), 1691-1700. https://doi.org/10.1093/eurjpc/zwab020
Cittadini, Antonio, et al. "Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry." European journal of preventive cardiology vol. 28,15 (2021): 1691-1700. doi: https://doi.org/10.1093/eurjpc/zwab020
Cittadini A, Salzano A, Iacoviello M, Triggiani V, Rengo G, Cacciatore F, Maiello C, Limongelli G, Masarone D, Perticone F, Cimellaro A, Perrone Filardi P, Paolillo S, Mancini A, Volterrani M, Vriz O, Castello R, Passantino A, Campo M, Modesti PA, De Giorgi A, Monte IP, Puzzo A, Ballotta A, D'Assante R, Arcopinto M, Gargiulo P, Sciacqua A, Bruzzese D, Colao A, Napoli R, Suzuki T, Eagle KA, Ventura HO, Marra AM, Bossone E. Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry. Eur J Prev Cardiol. 2021 Dec 29;28(15):1691-1700. doi: 10.1093/eurjpc/zwab020. PMID: 33693736.
Copy Download .nbib Format: NLM
Understanding the Pathophysiology to Improve the Therapeutic Management: Focus on Metabolic and Hormonal Comorbidities in Heart Failure.

Heart failure clinics

Perrone Filardi P, Bossone E.
PMID: 31079701
Heart Fail Clin. 2019 Jul;15(3):xi-xii. doi: 10.1016/j.hfc.2019.04.001.

No abstract available.

Cite
Perrone Filardi P, Bossone E. Understanding the Pathophysiology to Improve the Therapeutic Management: Focus on Metabolic and Hormonal Comorbidities in Heart Failure. Heart Fail Clin. 2019;15(3):xi-xiidoi: 10.1016/j.hfc.2019.04.001.
Perrone Filardi, P., & Bossone, E. (2019). Understanding the Pathophysiology to Improve the Therapeutic Management: Focus on Metabolic and Hormonal Comorbidities in Heart Failure. Heart failure clinics, 15(3), xi-xii. https://doi.org/10.1016/j.hfc.2019.04.001
Perrone Filardi, Pasquale, and Bossone, Eduardo. "Understanding the Pathophysiology to Improve the Therapeutic Management: Focus on Metabolic and Hormonal Comorbidities in Heart Failure." Heart failure clinics vol. 15,3 (2019): xi-xii. doi: https://doi.org/10.1016/j.hfc.2019.04.001
Perrone Filardi P, Bossone E. Understanding the Pathophysiology to Improve the Therapeutic Management: Focus on Metabolic and Hormonal Comorbidities in Heart Failure. Heart Fail Clin. 2019 Jul;15(3):xi-xii. doi: 10.1016/j.hfc.2019.04.001. PMID: 31079701.
Copy Download .nbib Format: NLM
Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652].

International journal of cardiology

Paolillo S, Salvioni E, Perrone Filardi P, Bonomi A, Sinagra G, Gentile P, Gargiulo P, Scoccia A, Cosentino N, Gugliandolo P, Badagliacca R, Lagioia R, Correale M, Frigerio M, Perna E, Piepoli M, Re F, Raimondo R, Minà C, Clemenza F, Bussotti M, Limongelli G, Gravino R, Passantino A, Magrì D, Parati G, Caravita S, Scardovi AB, Arcari L, Vignati C, Mapelli M, Cattadori G, Cavaliere C, Corrà U, Agostoni P.
PMID: 33640418
Int J Cardiol. 2021 Jun 15;333:252. doi: 10.1016/j.ijcard.2021.02.045. Epub 2021 Feb 26.

No abstract available.

Cite
Paolillo S, Salvioni E, Perrone Filardi P, et al. Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652]. Int J Cardiol. 2021;333:252doi: 10.1016/j.ijcard.2021.02.045.
Paolillo, S., Salvioni, E., Perrone Filardi, P., Bonomi, A., Sinagra, G., Gentile, P., Gargiulo, P., Scoccia, A., Cosentino, N., Gugliandolo, P., Badagliacca, R., Lagioia, R., Correale, M., Frigerio, M., Perna, E., Piepoli, M., Re, F., Raimondo, R., Minà, C., Clemenza, F., Bussotti, M., Limongelli, G., Gravino, R., Passantino, A., Magrì, D., Parati, G., Caravita, S., Scardovi, A. B., Arcari, L., Vignati, C., Mapelli, M., Cattadori, G., Cavaliere, C., Corrà, U., Agostoni, P. (2021). Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652]. International journal of cardiology, 333252. https://doi.org/10.1016/j.ijcard.2021.02.045
Paolillo, S, et al. "Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652]." International journal of cardiology vol. 333 (2021): 252. doi: https://doi.org/10.1016/j.ijcard.2021.02.045
Paolillo S, Salvioni E, Perrone Filardi P, Bonomi A, Sinagra G, Gentile P, Gargiulo P, Scoccia A, Cosentino N, Gugliandolo P, Badagliacca R, Lagioia R, Correale M, Frigerio M, Perna E, Piepoli M, Re F, Raimondo R, Minà C, Clemenza F, Bussotti M, Limongelli G, Gravino R, Passantino A, Magrì D, Parati G, Caravita S, Scardovi AB, Arcari L, Vignati C, Mapelli M, Cattadori G, Cavaliere C, Corrà U, Agostoni P. Corrigendum to "Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database" [Int J Cardiol. 2020 Oct 15; 317: 103-110. PMID: 32360652]. Int J Cardiol. 2021 Jun 15;333:252. doi: 10.1016/j.ijcard.2021.02.045. Epub 2021 Feb 26. PMID: 33640418.
Copy Download .nbib Format: NLM
SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.

International journal of cardiology

Giaccari A, Pontremoli R, Perrone Filardi P.
PMID: 34979145
Int J Cardiol. 2022 Jan 01; doi: 10.1016/j.ijcard.2021.12.050. Epub 2022 Jan 01.

Sodium-glucose cotransporter-2 inhibitors (SGLT-2i), initially studied and approved for the treatment of diabetes, are now becoming a promising class of agents to treat heart failure (HF) and chronic kidney disease (CKD), even in patients without diabetes. While the potential...

Cite
Giaccari A, Pontremoli R, Perrone Filardi P. SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice. Int J Cardiol. 2022;doi: 10.1016/j.ijcard.2021.12.050.
Giaccari, A., Pontremoli, R., & Perrone Filardi, P. (2022). SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice. International journal of cardiology, . https://doi.org/10.1016/j.ijcard.2021.12.050
Giaccari, Andrea, et al. "SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice." International journal of cardiology vol. (2022). doi: https://doi.org/10.1016/j.ijcard.2021.12.050
Giaccari A, Pontremoli R, Perrone Filardi P. SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice. Int J Cardiol. 2022 Jan 01; doi: 10.1016/j.ijcard.2021.12.050. Epub 2022 Jan 01. PMID: 34979145.
Copy Download .nbib Format: NLM
Renal protection in chronic heart failure: focus on sacubitril/valsartan.

European heart journal. Cardiovascular pharmacotherapy

Pontremoli R, Borghi C, Perrone Filardi P.
PMID: 33822031
Eur Heart J Cardiovasc Pharmacother. 2021 Sep 21;7(5):445-452. doi: 10.1093/ehjcvp/pvab030.

Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF) and increases the risk of overall and cardiovascular (CV) mortality. Despite evidence supporting the effectiveness of angiotensin-converting enzyme inhibitors (ACE-Is), angiotensin receptor blockers, and mineralocorticoid...

Cite
Pontremoli R, Borghi C, Perrone Filardi P. Renal protection in chronic heart failure: focus on sacubitril/valsartan. Eur Heart J Cardiovasc Pharmacother. 2021;7(5):445-452doi: 10.1093/ehjcvp/pvab030.
Pontremoli, R., Borghi, C., & Perrone Filardi, P. (2021). Renal protection in chronic heart failure: focus on sacubitril/valsartan. European heart journal. Cardiovascular pharmacotherapy, 7(5), 445-452. https://doi.org/10.1093/ehjcvp/pvab030
Pontremoli, Roberto, et al. "Renal protection in chronic heart failure: focus on sacubitril/valsartan." European heart journal. Cardiovascular pharmacotherapy vol. 7,5 (2021): 445-452. doi: https://doi.org/10.1093/ehjcvp/pvab030
Pontremoli R, Borghi C, Perrone Filardi P. Renal protection in chronic heart failure: focus on sacubitril/valsartan. Eur Heart J Cardiovasc Pharmacother. 2021 Sep 21;7(5):445-452. doi: 10.1093/ehjcvp/pvab030. PMID: 33822031; PMCID: PMC8453284.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries